Tildacerfont
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tildacerfont, covering 2025-07-08 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH [Phase 2]